Emulsion Versus Suspension in Chemoembolization for Hepatocellular Carcinoma

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 9, 2016

Primary Completion Date

February 28, 2023

Study Completion Date

April 28, 2023

Conditions
Hepatocellular Carcinoma
Interventions
PROCEDURE

Lipiodol-based transarterial chemoembolization

Arterial catheterization to segmental, subsegmental, or sub-subsegmental level was achieved depending on the tumor size, to gain arterial access as close to the tumors as possible. The formulation was delivered under fluoroscopic control until the vasculature of all tumors was entirely filled, or until the maximum dose was reached.

Trial Locations (1)

Unknown

Department of Imaging and Interventional Radiology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER

NCT03268499 - Emulsion Versus Suspension in Chemoembolization for Hepatocellular Carcinoma | Biotech Hunter | Biotech Hunter